Latest Technology Platform News

REA Group Ltd reported a solid 5% revenue increase for H1 FY26, driven by strong buyer demand and strategic AI integration, alongside announcing a $200 million on-market share buy-back.

DataWorks has secured a significant contract extension with iGaming Ontario, adding over C$12.5 million to its Centralised Self-Exclusion program services. This move strengthens its recurring revenue and solidifies its RegTech division’s profitability.

Jumbo Interactive’s preliminary 1H26 results reveal robust double-digit growth driven by SaaS and Managed Services, despite a quieter jackpot landscape. The recent acquisitions in the UK and US add momentum but introduce new accounting complexities.

1414 Degrees has achieved a key milestone with its SiNTL silicon anode material reaching 500 mAh/g, matching current commercial standards ahead of schedule and setting sights on 600 mAh/g within a year.

Adheris Health has expanded its operating cost reduction program, aiming for more than 30% savings by FY27, while refocusing on high-growth pharmaceutical categories and enhancing its AI-powered patient engagement platform.

Halo Technologies reports a strategic pivot under new CEO Peter Oxlade, adopting a capital-light B2B model in the UK and expanding its Australian managed funds offering, while maintaining stable subscription revenue despite seasonal headwinds.

Clean TeQ Water Limited reported strong operational progress in Q2 FY26, highlighted by a $19 million contract with Rio Tinto and a successful $6 million capital raise. The company is advancing multiple water treatment and critical minerals projects globally.

Pure One Corporation Limited has advanced its zero-emission mobility strategy with a new local vehicle assembly partnership, expanded US hydrogen market collaborations, and progressed the spin-out of its Australian gas assets via Eastern Gas IPO.

Swoop Holdings reports a robust 53% increase in customer receipts for the first half of FY26, driven by NBN and Mobile growth, while investing heavily in technology and launching a strategic refocus.

Adheris Health reported a sharp decline in Q2 FY26 revenue but is pushing ahead with leadership changes, cost cuts, and a new digital platform to reshape its future.

Optiscan Imaging Ltd has made significant strides in clinical studies and regulatory readiness, partnering with Australian Clinical Labs and launching new cancer imaging trials as it prepares for multiple FDA submissions in 2026.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.